• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)会具有噬菌体行为或诱导其他噬菌体的活性吗?

Could SARS-CoV-2 Have Bacteriophage Behavior or Induce the Activity of Other Bacteriophages?

作者信息

Brogna Carlo, Brogna Barbara, Bisaccia Domenico Rocco, Lauritano Francesco, Marino Giuliano, Montano Luigi, Cristoni Simone, Prisco Marina, Piscopo Marina

机构信息

Department of Research, Craniomed Group Facility Srl., 20091 Bresso, Italy.

Department of Radiology, Moscati Hospital, Contrada Amoretta, 83100 Avellino, Italy.

出版信息

Vaccines (Basel). 2022 Apr 29;10(5):708. doi: 10.3390/vaccines10050708.

DOI:10.3390/vaccines10050708
PMID:35632464
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9143435/
Abstract

SARS-CoV-2 has become one of the most studied viruses of the last century. It was assumed that the only possible host for these types of viruses was mammalian eukaryotic cells. Our recent studies show that microorganisms in the human gastrointestinal tract affect the severity of COVID-19 and for the first time provide indications that the virus might replicate in gut bacteria. In order to further support these findings, in the present work, cultures of bacteria from the human microbiome and SARS-CoV-2 were analyzed by electron and fluorescence microscopy. The images presented in this article, in association with the nitrogen (N) isotope-labeled culture medium experiment, suggest that SARS-CoV-2 could also infect bacteria in the gut microbiota, indicating that SARS-CoV-2 could act as a bacteriophage. Our results add new knowledge to the understanding of the mechanisms of SARS-CoV-2 infection and fill gaps in the study of the interactions between SARS-CoV-2 and non-mammalian cells. These findings could be useful in suggesting specific new pharmacological solutions to support the vaccination campaign.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)已成为上个世纪研究最多的病毒之一。人们曾认为这类病毒唯一可能的宿主是哺乳动物真核细胞。我们最近的研究表明,人类胃肠道中的微生物会影响新冠肺炎的严重程度,并首次提供迹象表明该病毒可能在肠道细菌中复制。为了进一步支持这些发现,在本研究中,我们通过电子显微镜和荧光显微镜对来自人类微生物组的细菌培养物和SARS-CoV-2进行了分析。本文呈现的图像,结合氮(N)同位素标记培养基实验,表明SARS-CoV-2也可能感染肠道微生物群中的细菌,这表明SARS-CoV-2可能作为一种噬菌体发挥作用。我们的研究结果为理解SARS-CoV-2感染机制增添了新知识,并填补了SARS-CoV-2与非哺乳动物细胞相互作用研究的空白。这些发现可能有助于提出特定的新药理学解决方案,以支持疫苗接种运动。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9c9/9143435/cd538eeeb160/vaccines-10-00708-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9c9/9143435/67288cd6e606/vaccines-10-00708-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9c9/9143435/74b18bb38dab/vaccines-10-00708-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9c9/9143435/ac879f79e288/vaccines-10-00708-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9c9/9143435/cd538eeeb160/vaccines-10-00708-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9c9/9143435/67288cd6e606/vaccines-10-00708-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9c9/9143435/74b18bb38dab/vaccines-10-00708-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9c9/9143435/ac879f79e288/vaccines-10-00708-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9c9/9143435/cd538eeeb160/vaccines-10-00708-g004.jpg

相似文献

1
Could SARS-CoV-2 Have Bacteriophage Behavior or Induce the Activity of Other Bacteriophages?严重急性呼吸综合征冠状病毒2(SARS-CoV-2)会具有噬菌体行为或诱导其他噬菌体的活性吗?
Vaccines (Basel). 2022 Apr 29;10(5):708. doi: 10.3390/vaccines10050708.
2
Analysis of Bacteriophage Behavior of a Human RNA Virus, SARS-CoV-2, through the Integrated Approach of Immunofluorescence Microscopy, Proteomics and D-Amino Acid Quantification.通过免疫荧光显微镜、蛋白质组学和 D-氨基酸定量分析综合方法分析人类 RNA 病毒 SARS-CoV-2 的噬菌体行为。
Int J Mol Sci. 2023 Feb 15;24(4):3929. doi: 10.3390/ijms24043929.
3
Who Is the Intermediate Host of RNA Viruses? A Study Focusing on SARS-CoV-2 and Poliovirus.谁是RNA病毒的中间宿主?一项聚焦于新冠病毒和脊髓灰质炎病毒的研究。
Microorganisms. 2024 Mar 23;12(4):643. doi: 10.3390/microorganisms12040643.
4
Review article: Probiotics, prebiotics and dietary approaches during COVID-19 pandemic.综述文章:2019冠状病毒病大流行期间的益生菌、益生元及饮食方法
Trends Food Sci Technol. 2021 Feb;108:187-196. doi: 10.1016/j.tifs.2020.12.009. Epub 2020 Dec 14.
5
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.
6
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.COVID-19 患者住院期间肠道微生物组的变化。
Gastroenterology. 2020 Sep;159(3):944-955.e8. doi: 10.1053/j.gastro.2020.05.048. Epub 2020 May 20.
7
COVID-19 - gastrointestinal and gut microbiota-related aspects.COVID-19 - 与胃肠道和肠道微生物群相关的方面。
Eur Rev Med Pharmacol Sci. 2020 Oct;24(20):10853-10859. doi: 10.26355/eurrev_202010_23448.
8
SARS-CoV-2 surrogate (Phi6) environmental persistence within free-living amoebae.SARS-CoV-2 假病毒(Phi6)在自由生活阿米巴虫内的环境持久性。
J Water Health. 2022 Jan;20(1):83-91. doi: 10.2166/wh.2021.167.
9
Gut microbiota and Covid-19- possible link and implications.肠道微生物群与新冠病毒(COVID-19):可能的联系及影响。
Virus Res. 2020 Aug;285:198018. doi: 10.1016/j.virusres.2020.198018. Epub 2020 May 13.
10
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗(灭活,Vero 细胞)有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.

引用本文的文献

1
New Neonatal and Prenatal Approach to Home Therapy with Amoxicillin, Rifaximin, and Anti-Inflammatory Drugs for Pregnant Women with COVID-19 Infections-Monitoring of Fetal Growth as a Prognostic Factor: A Triple Case Series (N.A.T.H.A.N.).新冠病毒感染孕妇使用阿莫西林、利福昔明和抗炎药物进行家庭治疗的新生儿和产前新方法——将胎儿生长监测作为预后因素:三例病例系列研究(N.A.T.H.A.N.)
Biomedicines. 2025 Jul 30;13(8):1858. doi: 10.3390/biomedicines13081858.
2
Blood Transcriptome Profiling Highlights the Role of Intestinal Bacterial Translocation in Severe COVID-19.血液转录组分析突显了肠道细菌易位在重症 COVID-19 中的作用。
Pathogens. 2025 Apr 14;14(4):381. doi: 10.3390/pathogens14040381.
3

本文引用的文献

1
Toxin-like peptides in plasma, urine and faecal samples from COVID-19 patients.新冠病毒患者的血浆、尿液和粪便样本中的类毒素肽。
F1000Res. 2021 Jul 8;10:550. doi: 10.12688/f1000research.54306.2. eCollection 2021.
2
SARS-CoV-2 Causes Mitochondrial Dysfunction and Mitophagy Impairment.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)导致线粒体功能障碍和线粒体自噬受损。
Front Microbiol. 2022 Jan 6;12:780768. doi: 10.3389/fmicb.2021.780768. eCollection 2021.
3
Potential Associations Between Microbiome and COVID-19.微生物群与2019冠状病毒病之间的潜在关联。
Relationship Between Gut Microbiota and the Clinical Course of COVID-19 Disease.
肠道微生物群与COVID-19疾病临床进程之间的关系
Viruses. 2025 Apr 2;17(4):520. doi: 10.3390/v17040520.
4
Performance of Subgenomic RT-PCR for Predicting SARS-CoV-2 Infectivity Compared to Genomic RT-PCR and Culture Isolation.与基因组逆转录聚合酶链反应(RT-PCR)和培养分离相比,亚基因组RT-PCR在预测严重急性呼吸综合征冠状病毒2(SARS-CoV-2)传染性方面的性能
J Med Virol. 2025 May;97(5):e70363. doi: 10.1002/jmv.70363.
5
Lentinan Reduces Transmission Efficiency of COVID-19 by Changing Aerodynamic Characteristic of Exhaled SARS-CoV-2 Aerosols in Golden Hamsters.香菇多糖通过改变金黄仓鼠呼出的新冠病毒气溶胶的空气动力学特性降低新冠病毒传播效率。
Microorganisms. 2025 Mar 5;13(3):597. doi: 10.3390/microorganisms13030597.
6
The first report on detecting SARS-CoV-2 inside bacteria of  the human gut microbiome: A case series on asymptomatic family members and a child with COVID-19.首篇关于在人类肠道微生物组细菌内检测到 SARS-CoV-2 的报告:一项针对无症状家庭成员和一名 COVID-19 患儿的病例系列研究。
F1000Res. 2024 Oct 16;11:135. doi: 10.12688/f1000research.77421.2. eCollection 2022.
7
Gut microbe-host interactions in post-COVID syndrome: a debilitating or restorative partnership?新冠后综合征中的肠道微生物-宿主相互作用:是一种使人虚弱还是恢复性的伙伴关系?
Gut Microbes. 2024 Jan-Dec;16(1):2402544. doi: 10.1080/19490976.2024.2402544. Epub 2024 Sep 17.
8
Gut microbiota: a potential influencer of insomnia occurring after COVID-19 infection.肠道微生物群:新冠病毒感染后失眠的潜在影响因素
Front Psychiatry. 2024 Jul 23;15:1423715. doi: 10.3389/fpsyt.2024.1423715. eCollection 2024.
9
Development and characterization of a multimeric recombinant protein using the spike protein receptor binding domain as an antigen to induce SARS-CoV-2 neutralization.利用刺突蛋白受体结合域作为抗原开发和鉴定多聚体重组蛋白以诱导 SARS-CoV-2 中和作用。
Immun Inflamm Dis. 2024 Jul;12(7):e1353. doi: 10.1002/iid3.1353.
10
Exploring the Pathophysiology of Long COVID: The Central Role of Low-Grade Inflammation and Multisystem Involvement.探索长新冠的病理生理学:低度炎症和多系统受累的核心作用。
Int J Mol Sci. 2024 Jun 9;25(12):6389. doi: 10.3390/ijms25126389.
Front Med (Lausanne). 2021 Dec 22;8:785496. doi: 10.3389/fmed.2021.785496. eCollection 2021.
4
An Mixed Infection Model With Commensal and Pathogenic Staphylococci for the Exploration of Interspecific Interactions and Their Impacts on Skin Physiology.共生和致病性葡萄球菌混合感染模型,用于探索种间相互作用及其对皮肤生理的影响。
Front Cell Infect Microbiol. 2021 Sep 16;11:712360. doi: 10.3389/fcimb.2021.712360. eCollection 2021.
5
Interactions of Bacteriophages with Animal and Human Organisms-Safety Issues in the Light of Phage Therapy.噬菌体与动物和人体组织的相互作用——噬菌体治疗视角下的安全性问题。
Int J Mol Sci. 2021 Aug 19;22(16):8937. doi: 10.3390/ijms22168937.
6
SARS-CoV-2 spike and its adaptable furin cleavage site.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白及其适应性弗林蛋白酶切割位点
Lancet Microbe. 2021 Oct;2(10):e488-e489. doi: 10.1016/S2666-5247(21)00174-9. Epub 2021 Aug 6.
7
Increase of SARS-CoV-2 RNA load in faecal samples prompts for rethinking of SARS-CoV-2 biology and COVID-19 epidemiology.粪便样本中 SARS-CoV-2 RNA 载量的增加提示我们需要重新思考 SARS-CoV-2 的生物学和 COVID-19 的流行病学。
F1000Res. 2021 May 11;10:370. doi: 10.12688/f1000research.52540.3. eCollection 2021.
8
Hidden in Plain Sight: Natural Products of Commensal Microbiota as an Environmental Selection Pressure for the Rise of New Variants of SARS-CoV-2.隐匿于众目睽睽之下:共生微生物群的天然产物作为新冠病毒新变种出现的环境选择压力
Chembiochem. 2021 Oct 13;22(20):2946-2950. doi: 10.1002/cbic.202100346. Epub 2021 Jul 26.
9
Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19.新型冠状病毒肺炎患者鼻咽微生物组与代谢组之间的关联
Synth Syst Biotechnol. 2021 Sep;6(3):135-143. doi: 10.1016/j.synbio.2021.06.002. Epub 2021 Jun 14.
10
Characterization of Feces-Derived Bacterial Membrane Vesicles and the Impact of Their Origin on the Inflammatory Response.粪便来源的细菌膜囊泡的表征及其来源对炎症反应的影响。
Front Cell Infect Microbiol. 2021 May 7;11:667987. doi: 10.3389/fcimb.2021.667987. eCollection 2021.